Nikolaos Tasis

Mr. Nikolaos Tasis

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2021 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
DMDimitrios K. Manatakis
Dimitrios K. Manatakis
NTNikolaos Tasis
Nikolaos Tasis
MAMaria Ioanna Antonopoulou
Maria Ioanna Antonopoulou
PAPetros Anagnostopoulos
Petros Anagnostopoulos
VAVasileios Acheimastos
Vasileios Acheimastos
EXEvaghelos Xynos
Evaghelos Xynos

28 February 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
DMDimitrios K. Manatakis
Dimitrios K. Manatakis
MTMaria Tzardi
Maria Tzardi
John SouglakosJohn Souglakos
John Souglakos
JTJohn Tsiaoussis
John Tsiaoussis
CAChristos Agalianos
Christos Agalianos
EXEvaghelos Xynos
Evaghelos Xynos
Background: Colon cancer surgery is a complex clinical pathway and traditional quality metrics may exhibit significant variability between hospitals and healthcare providers. The Textbook Outcome (TO) is a composite quality marker capturing the fraction of patients, in whom all desired short-term outcomes of care are realised. The aim of the present study was to assess the TO in a series of non-metastatic colon cancer patients treated with curative intent, with emphasis on long-term survival. Methods: Stage I–III colon cancer patients, who underwent curative colectomy following the Complete Mesocolic Excision principles, were retrospectively identified from the institutional database. TO was defined as (i) hospital survival, (ii) radical resection, (iii) no major complications, (iv) no reintervention, (v) no unplanned stoma and (vi) no prolonged hospital stay or readmission. Results: In total, 128 patients (male 61%, female 39%, mean age 70.7 ± 11.4 years) were included in the final analysis. Overall, 60.2% achieved a TO. The highest rates were observed for “hospital survival” and “no unplanned stoma” (96.9% and 97.7%), while the lowest rates were for “no major complications” and “no prolonged hospital stay” (69.5% and 75%). Older age, left-sided resections and pT4 tumours were factors limiting the chances of a TO. The 5-year overall and 5-year cancer-specific survival were significantly better in the TO versus non-TO subgroup (81% vs. 59%, p = 0.009, and 86% vs. 65%, p = 0.02, respectively). Conclusions: Outcomes in colon cancer surgery may be affected by patient-, doctor- and hospital-related factors. TO represents those patients who achieve the optimal perioperative results, and is furthermore associated with improved long-term cancer survival.

16 December 2022 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
Belinda De SimoneBelinda De Simone
Belinda De Simone
FAFikri M. Abu-Zidan
Fikri M. Abu-Zidan
ECElie Chouillard
Elie Chouillard
SSSalomone Di Saverio
Salomone Di Saverio
MSMassimo Sartelli
Massimo Sartelli
Fausto CatenaFausto Catena
Fausto Catena
Background: The incidence of the highly morbid and potentially lethal gangrenous cholecystitis was reportedly increased during the COVID-19 pandemic. The aim of the ChoCO-W study was to compare the clinical findings and outcomes of acute cholecystitis in patients who had COVID-19 disease with those who did not. Methods: Data were prospectively collected over 6 months (October 1, 2020, to April 30, 2021) with 1-month follow-up. In October 2020, Delta variant of SARS CoV-2 was isolated for the first time. Demographic and clinical data were analyzed and reported according to the STROBE guidelines. Baseline characteristics and clinical outcomes of patients who had COVID-19 were compared with those who did not. Results: A total of 2893 patients, from 42 countries, 218 centers, involved, with a median age of 61.3 (SD: 17.39) years were prospectively enrolled in this study; 1481 (51%) patients were males. One hundred and eighty (6.9%) patients were COVID-19 positive, while 2412 (93.1%) were negative. Concomitant preexisting diseases including cardiovascular diseases (p < 0.0001), diabetes (p < 0.0001), and severe chronic obstructive airway disease (p = 0.005) were significantly more frequent in the COVID-19 group. Markers of sepsis severity including ARDS (p < 0.0001), PIPAS score (p < 0.0001), WSES sepsis score (p < 0.0001), qSOFA (p < 0.0001), and Tokyo classification of severity of acute cholecystitis (p < 0.0001) were significantly higher in the COVID-19 group. The COVID-19 group had significantly higher postoperative complications (32.2% compared with 11.7%, p < 0.0001), longer mean hospital stay (13.21 compared with 6.51 days, p < 0.0001), and mortality rate (13.4% compared with 1.7%, p < 0.0001). The incidence of gangrenous cholecystitis was doubled in the COVID-19 group (40.7% compared with 22.3%). The mean wall thickness of the gallbladder was significantly higher in the COVID-19 group [6.32 (SD: 2.44) mm compared with 5.4 (SD: 3.45) mm; p < 0.0001]. Conclusions: The incidence of gangrenous cholecystitis is higher in COVID patients compared with non-COVID patients admitted to the emergency department with acute cholecystitis. Gangrenous cholecystitis in COVID patients is associated with high-grade Clavien-Dindo postoperative complications, longer hospital stay and higher mortality rate. The open cholecystectomy rate is higher in COVID compared with non -COVID patients. It is recommended to delay the surgical treatment in COVID patients, when it is possible, to decrease morbidity and mortality rates. COVID-19 infection and gangrenous cholecystistis are not absolute contraindications to perform laparoscopic cholecystectomy, in a case by case evaluation, in expert hands. Graphical
1

4 August 2021 in Hernia
Verified
Journal Article
Closed access
PDF file
NTNikolaos Tasis
Nikolaos Tasis
ITI. Tsouknidas
I. Tsouknidas
MAM. I. Antonopoulou
M. I. Antonopoulou
VAV. Acheimastos
V. Acheimastos
DMDimitrios K. Manatakis
Dimitrios K. Manatakis

4 November 2020 in Hormones
Verified
Journal Article
Closed access
PDF file
DMDimitrios K. Manatakis
Dimitrios K. Manatakis
NTNikolaos Tasis
Nikolaos Tasis
MAMaria Ioanna Antonopoulou
Maria Ioanna Antonopoulou
AKAthanasios Kordelas
Athanasios Kordelas
DBDimitrios Balalis
Dimitrios Balalis
STSophia Tseleni-Balafouta
Sophia Tseleni-Balafouta

1 October 2022 in Rare Tumors
Verified
Journal Article
Open access
NTNikolaos Tasis
Nikolaos Tasis
APAntonia A. Prountzopoulou
Antonia A. Prountzopoulou
ESEvangelia Skafida
Evangelia Skafida
MAMaria Arnaouti
Maria Arnaouti
TTTheodoros Tsirlis
Theodoros Tsirlis
DKDimitrios P. Korkolis
Dimitrios P. Korkolis
Pancreatic mature cystic teratomas are very rare with limited cases found in the literature. These lesions raise a diagnostic challenge and complicate the surgical approach not only because of their anatomic position but also because of their ever-growing size. An elusive diagnosis, usually leads to the operative theatre where surgical resection takes place. We present a rare case of a large pancreatic cystic teratoma extending into the mediastinum in a 29-year-old woman which was succesfully managed with en-bloc distal pancreatectomy and spleenectomy.